18 Sep 2017 Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS Infection
15 Sep 2017 Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic’s Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer
14 Sep 2017 SELLAS' Galinpepimut-S Induces Specific, Robust and Durable Immune Responses in Patients With High-Risk Multiple Myeloma - Correlated With Clinical Benefit
14 Sep 2017 Successful Phase III trial for ALK’s tree allergy SLIT-tablet
14 Sep 2017 OncBioMune Meets Primary Objective in Trial of ProscaVax Immunotherapy Vaccine for Prostate Cancer
14 Sep 2017 Argos Therapeutics Reports on Interim Analysis of Phase 3 ADAPT Trial Presented at ESMO 2017 Congress
14 Sep 2017 FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over
12 Sep 2017 AC Immune completes Recruitment for Low-Dose Cohort of Participants in World's First Clinical Trial for anti-Abeta Vaccine Targeting Alzheimer's Disease-like Characteristics in Individuals with Down Syndrome
11 Sep 2017 Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In Patients with Recurrent Prostate Cancer
08 Sep 2017 New Randomized Data From CMB305 + Checkpoint Inhibitor Study Demonstrate Greater Clinical Benefit and Immune Response
07 Sep 2017 Anergis Announces Top Line Results from Large-Scale ATIBAR Trial with Ultra-Fast Allergy Immunotherapy AllerT
06 Sep 2017 Argos Announces First Dosing of HIV Patient with AGS-004 Derived from the Latent Viral Reservoir
06 Sep 2017 AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
06 Sep 2017 Aelix Therapeutics Enrolls First Patient In Company’s Initial Therapeutic HIV Vaccine Clinical Trial
05 Sep 2017 VAXIMM Announces Preclinical Results with Novel Oral T-cell Cancer Immunotherapies Being Presented at Third CRI-CIMT-EATI-AACR Conference
01 Sep 2017 PepVax begins efficacy study for lead candidate
29 Aug 2017 Gliknik Announces Dosing Of First Patient In Phase 2 Trial Targeting Prevention Of Recurrence Of High-Risk Oral Cavity Cancer
21 Aug 2017 Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial
16 Aug 2017 VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme
11 Aug 2017 Immunicum AB (publ) Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel
02 Aug 2017 Madison Vaccines Announces First Patient Dosed in an Expanded Combination Trial of MVI-816 Plus Keytruda® for Metastatic, Treatment-Resistant Prostate Cancer
01 Aug 2017 Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B
29 Jul 2017 VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
27 Jul 2017 Chikungunya-fever: Themis Bioscience starts phase II clinical study in endemic area
27 Jul 2017 CureVac Announces Publication in The Lancet of First-Ever Human Proof-of-Concept Study Investigating the Safety and Immunogenicity of a Prophylactic mRNA Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up